ESMO 2019: Early Study Suggests Role for Ribociclib in Aggressive Meningioma
Drug reaches high concentrations in tumor tissue and has measurable pharmacodynamic effects
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.